Article
GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Pharmacogenomics - 1 Mar 2016
Liang Kung-Hao, Lin Chih-Lang, Chen Sung-Fang, Chiu Chih-Wei, Yang Pei-Ching, Chang Ming-Ling, Lin Chen-Chun, Sung Kai-Feng, Yeh Cassandra, Hung Chien-Fu, Chien Rong-Nan, Yeh Chau-Ting
Abstract excerpt
AIM: Transcatheter arterial chemoembolization is currently the standard treatment in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer stage B. Genomic variants of GALNT14 were recently identified as effective predictors for chemotherapy responses in Barcelona Clinic Liver Cancer stage C patients. METHODS: We investigated the prognosis predictive value of GALNT14 genotypes in 327 hepatocelluar...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
